Work

Supplemental Figure S4 from A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma

Year: 2023

Type: supplementary-materials

Abstract: Progression-free survival of responders (R) and non-responders (NR) in all subjects (combined test and validation cohorts).

DOI: 10.1158/1078-0432.22454894.v1

Authors: Motonobu Saito, Kouya Shiraishi, Kenji Matsumoto, Aaron J. Schetter, Hiroko Ogata-Kawata, Naoto Tsuchiya, Hideo Kunitoh, Hiroshi Nokihara, Shun-ichi Watanabe, Koji Tsuta, Kensuke Kumamoto, Seiichi Takenoshita, Jun Yokota, Curtis C. Harris, Takashi Kohno

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361909925

Cites:

Cited by:

Related to: 10